Antimetabolites, Antineoplastic clinical trials at UCSF
1 in progress, 0 open to eligible people
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Sorry, in progress, not accepting new patients
The purpose of this study is to compare whether there is a delay or prevention of recurrence or death in subjects with surgically removed pancreatic cancer who then take nab-paclitaxel in combination with gemcitabine compared to those who take gemcitabine alone.
San Francisco, California and other locations